Zurzuvae (zuranolone) — Highmark
postpartum depression (moderate to severe)
Initial criteria
- age ≥ 18 years
- diagnosis of postpartum depression (ICD-10: F53.0), classified as moderate to severe
- prescriber attests that symptom onset began during the third trimester of pregnancy or up to 4 weeks post-delivery
- member is ≤ 12 months postpartum
Approval duration
30 days